Guitard Joelle, Ribes David, Kamar Nassim, Muscari Fabrice, Cointault Olivier, Lavayssière Laurence, Suc Bertrand, Esposito Laure, Peron Jean-Marie, Rostaing Lionel
Multiorgan Transplant Unit, University Hospital, CHU Rangueil, Toulouse, France.
Ren Fail. 2006;28(5):419-25. doi: 10.1080/08860220600683607.
Chronic renal failure (CRF) is increasingly prevalent in solid-organ-transplant patients. This is in part related to the long-term use of calcineurin inhibitor (CNI) agents. However, in orthotopic liver-transplant (OLT) patients, the effects of superimposed hepatitis C virus (HCV)-related renal lesions could also be a factor. The aim of this cohort study (February 2000 to September, 2003) was to identify the predictive factors at one year post-transplantation for CRF in OLT patients associated with induction therapies. CRF was defined as having a creatinine clearance (CC) lower than 60 mL/min. Of the 97 transplants performed during that period, 72 were still functioning after one year. Of these, 33 patients (45.8%) had CRF. In univariate analysis, the predicting factors for CRF were recipient sex (female), initial liver disease (HCV-related cirrhosis), pre-transplant CC (<80 mL/mn), and post-transplant serum creatinine >130 micromol/L at day 3 and months (M) 1, 3, and 6. In multivariate analysis, the independent predictive factors for CRF included female sex [OR: 11.5 (2.3-58.3); p = 0.003], HCV infection [OR: 5.01 (1.1-22.7); p = 0.03], pre-OLT CC <80 mL/mn [OR: 5.4 (1.2-23.7); p = 0.025], and serum creatinine at M6 greater than 130 micromol/L [OR: 19.6 (3.7-102.5); p = 0.0004]. Among all of the predictive factors for post-OLT CRF, only one is modifiable: post-transplant serum creatinine, which could be, to some extent, related to the long-term use of CNIs.
慢性肾衰竭(CRF)在实体器官移植患者中越来越普遍。这部分与长期使用钙调神经磷酸酶抑制剂(CNI)药物有关。然而,在原位肝移植(OLT)患者中,叠加的丙型肝炎病毒(HCV)相关肾损害的影响也可能是一个因素。这项队列研究(2000年2月至2003年9月)的目的是确定OLT患者移植后一年与诱导治疗相关的CRF的预测因素。CRF定义为肌酐清除率(CC)低于60 mL/分钟。在该期间进行的97例移植中,72例在一年后仍在发挥功能。其中,33例患者(45.8%)患有CRF。在单因素分析中,CRF的预测因素为受者性别(女性)、初始肝病(HCV相关性肝硬化)、移植前CC(<80 mL/分钟)以及移植后第3天和第1、3、6个月时血清肌酐>130 μmol/L。在多因素分析中,CRF的独立预测因素包括女性性别[比值比(OR):11.5(2.3 - 58.3);p = 0.003]、HCV感染[OR:5.01(1.1 - 22.7);p = 0.03]、OLT前CC<80 mL/分钟[OR:5.4(1.2 - 23.7);p = 0.025]以及第6个月时血清肌酐大于130 μmol/L[OR:19.6(3.7 - 102.5);p = 0.0004]。在所有OLT后CRF的预测因素中,只有一个是可改变的:移植后血清肌酐,这在一定程度上可能与长期使用CNIs有关。